Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2022-06-30 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the Code of Conduct to Regulate, Monitor and Report of Trading by Insiders for trading ....
Regulatory Filings Classification · 95% confidence The document is a formal communication from Morepen Laboratories Limited addressed to stock exchanges regarding the closure of the trading window. It references SEBI (Prohibition of Insider Trading) Regulations and states that the trading window will be closed from July 1, 2022, until 48 hours after the announcement of unaudited financial results for the quarter ended June 30, 2022. The document does not contain any financial data, results, or detailed report content but is an announcement related to insider trading compliance and timing of financial results disclosure. It is short (1865 characters) and serves as a regulatory notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2022-06-30 English
Resignation
Regulatory Filings
2022-06-22 English
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that Mrs. Anju Suri (DIN: 00042033) vide her ....
Regulatory Filings
2022-06-22 English
Conversion
Capital/Financing Update Classification · 95% confidence The document is titled 'Outcome of the Meeting of the Board of Directors of the Company' and references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details the approval of allotment of equity shares pursuant to conversion of compulsorily convertible preference shares. The content focuses on the board meeting's decisions regarding share allotment and capital structure changes. There is no indication of full financial statements or comprehensive financial performance data, so it is not an Annual Report or Interim Report. The document is not a call transcript, audit report, or legal proceeding update. It is clearly an update on capital structure changes following a board meeting decision. Therefore, the document fits best under Capital/Financing Update (CAP). The document length (15,000 characters) and detailed share allotment data support this classification with high confidence.
2022-05-27 English
In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that the Board of Directors at their meeting held ....
Regulatory Filings
2022-05-27 English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read along with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, ....
Regulatory Filings
2022-05-24 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.